PUBLIC CONTRACT · 2021
MED. SPMS 2021_6
- Contract value
- €1,245.60
- Signed on
- 19 August 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7809682PUBLISHED DESCRIPTION
51014921
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- FRESENIUS KABI PHARMA PORTUGAL, LDA · Tax ID 504293753
- Bidder
- AMGEN BIOFARMACÊUTICA, LDA. · Tax ID 502942959
- Bidder
- Biogen Portugal Sociedade Farmacêutica Unipessoal Lda. · Tax ID 506415740
- Bidder
- SANDOZ FARMACÊUTICA, LDA · Tax ID 506985261
- Bidder
- LABORATÓRIOS PFIZER, LDA · Tax ID 500162166
- Bidder
- Abbvie Lda · Tax ID 510229050
- Bidder
- MYLAN, Lda · Tax ID 502248793
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €1,245.60
- Procedure base price
- €9,497.98
- Total effective price
- Not reported on Portal BASE
- Publication date
- 24 August 2021
- Award date
- 19 August 2021
- Signing date
- 19 August 2021
- Performance period
- 180 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5421108
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.